1-3 of 3
Maeve O’Reilly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, Kathleen Cheok, Maria Marzolini, William Townsend, Maeve O'Reilly, Amy A. Kirkwood, Andrea Kuhnl
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2872–2883.
https://doi.org/10.1182/bloodadvances.2022009019
Published: 2023
Includes: Supplemental data
Journal Articles

CD34 + -selected stem cell boost can safely improve cytopenias following CAR T-cell therapy

Khushnuma Mullanfiroze, Arina Lazareva, Jan Chu, Lindsey Williams, Saskia Burridge, Juliana Silva, Robert Chiesa, Kanchan Rao, Giovanna Lucchini, Sara Ghorashian, Maeve O’Reilly, Ben Carpenter, Victoria Grandage, Rachael Hough, Claire Roddie, Persis J. Amrolia
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4715–4718.
https://doi.org/10.1182/bloodadvances.2022007572
Published: 2022
Journal Articles

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma

Clinical Trials & Observations
Andrea Kuhnl, Claire Roddie, Amy A. Kirkwood, Tobias Menne, Maria Cuadrado, Maria A. V. Marzolini, Wendy Osborne, Robin Sanderson, Maeve O’Reilly, William Townsend, Reuben Benjamin, Victoria Potter, Piers E. M. Patten, Deborah Yallop, Stefan Voo, George S. Petrides, Nicola Mulholland, Irfan Kayani
Journal: Blood Advances
Blood Adv (2022) 6 (1): 321–326.
https://doi.org/10.1182/bloodadvances.2021005807
Published: 2022